Director, Medical Information

Key Responsibilities

• Develop and execute a comprehensive global medical information strategy to support launch and lifecycle of the VIASKIN® Patch platform
• Oversee the development of high-quality, evidence-based responses for global inquiries
• Establish and manage the infrastructure for intake, tracking, and reporting of medical inquiries, ensuring timely and compliant delivery of information
• Analyze medical information trends to provide actionable insights to Internal Stakeholders (Medical, Commercial, Clinical, and Regulatory teams)
• Supervise external medical information vendors to ensure operational excellence and adherence to DBV’s quality standards
• Contribute to other Medical Affairs and company projects, as needed

Qualifications

• Advanced scientific degree (PharmD, PhD, or MD) is required
• Expertise in immunology, allergy, or pediatric medicine preferred
• Minimum of 5 years of experience in the pharmaceutical or biotechnology industry in a medical information position
• Proven track record of supporting a product through a launch phase is a significant plus
• Comprehensive understanding of FDA regulations governing the communication of medical and scientific data
• Advanced ability to analyze complex clinical trial results and translate them into concise, evidence-based responses
• Strict adherence to PhRMA guidelines and international codes of practice (e.g., IFPMA)
• Highly developed technical writing skills and the ability to communicate effectively with diverse scientific and non-scientific audiences

Behavioral Skills

• Curiosity: Keep on exploring uncharted territories. Always ask “why?” and more importantly “why not”
• Courage: Take smart risks, mentor each other to always do better & be accountable for our choices, our opinions, and our actions
• Collaboration: Teamwork and spirit. Support each other and be equally involved in the achievement of our common goals
• Credibility: Be transparent, follow through and build trust. Educate ourselves about our unique technology

About DBV Technologies

DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively.

We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™, to develop treatment options for immunologic diseases with significant unmet medical need.

This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the immune system of patients through the skin.

Today, we are focused on exploring the use of Viaskin to address food allergies, a devastating condition that afflicts millions of patients. As an important milestone in our journey, we hope to offer the first epicutaneous immunotherapy treatment for peanut allergy.

Tomorrow, as pioneers, we will continue to explore the broad applications of this potential new class of immunotherapy, including treatments for patients suffering from inflammatory and autoimmune diseases.